EV/EBITDA
-3.69
+0.26+6.58%
10 min ago
Summary
- As of March 3, 2025, RXRX EV/EBITDA is -3.69, with a rise of +0.26 (+6.58%) during the most recent trading day.
- Over the past year, RXRX EV/EBITDA has increased by +4.67 (+55.86%).
- RXRX EV/EBITDA is now -89.23% below its all-time high of -1.95.
Performance
RXRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RXRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +6.6% | -6.5% | -5.0% |
| 1 m1 month | +3.4% | -3.4% | -2.6% |
| 3 m3 months | +24.7% | -8.5% | +0.1% |
| 6 m6 months | +6.3% | +14.6% | +15.4% |
| ytdytd | -7.9% | +7.8% | +5.9% |
| 1 y1 year | +55.9% | -40.6% | -43.6% |
| 5 y5 years | - | - | - |
RXRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -6.25 | +41.0% | |
| 3 m | 3-month | -3.11 | -18.6% | -6.25 | +41.0% |
| 6 m | 6-month | -3.11 | -18.6% | -6.25 | +41.0% |
| 1 y | 1-year | -3.11 | -18.6% | -8.83 | +58.2% |
| 3 y | 3-year | -1.95 | -89.2% | -11.41 | +67.7% |
| 5 y | 5-year | -1.95 | -89.2% | -65.18 | +94.3% |
| alltime | all time | -1.95 | -89.2% | -65.18 | +94.3% |
Recursion Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.69(+7.9%) |
| 2024 | -3.42(-45.6%) |
| Date | Value |
|---|---|
| 2023 | -6.29(+53.4%) |
| 2022 | -4.10(-72.8%) |
| 2021 | -15.09 |
FAQ
- What is Recursion Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Recursion Pharmaceuticals?
- What is RXRX EV/EBITDA year-to-date change?
- What is Recursion Pharmaceuticals EV/EBITDA year-on-year change?
What is Recursion Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of RXRX is -3.69
What is the all time high EV/EBITDA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high EV/EBITDA is -1.95
What is RXRX EV/EBITDA year-to-date change?
Recursion Pharmaceuticals EV/EBITDA has changed by -0.27 (-7.89%) since the beginning of the year
What is Recursion Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, RXRX EV/EBITDA has changed by +4.67 (+55.86%)